T3	Effect 31 51	cutaneous KS lesions
T4	Treatment 94 102	imatinib
T5	Subject 55 80	a patient affected by CML
T8	Drug 94 102	imatinib
T9	Treat-Disorder 77 80	CML
T6	Adverse_event 81 93	treated with
E1	Adverse_event:T6